News
Explores Behemoth Labz GLP‑1 nasal formulation's structural design, analytic insights, and intranasal incretin research relevance in preclinical metabolic ...
5d
The Brighterside of News on MSNBee venom quickly targets and kills aggressive breast cancer cellsFor centuries, the European honeybee has given people honey, wax, propolis, and even venom. Now, scientists are looking ...
Historically, sex-related differences have been underexplored in neurology. It is important to highlight the distinction ...
Eli Lilly's pill, orforglipron, is one step closer to becoming the first new, needle-free alternative in the booming market ...
Here we report that peripheral administration of antibodies against amyloid β-peptide, was sufficient to reduce amyloid burden.
Those on the highest 36 mg dose of the medicine on average lost 12.4 per cent of their body weight at 72 weeks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results